Anti-DDIT4L/REDD2 antibody [DDIT-03] - N-terminal
Be the first to review this product! Submit a review
|
(2 Publications)
Mouse Monoclonal DDIT4L/REDD2 antibody. N-terminal. Suitable for WB and reacts with Human samples. Cited in 2 publications. Immunogen corresponding to Recombinant Fragment Protein within Human DDIT4L aa 1-100.
View Alternative Names
REDD2, RTP801L, DDIT4L, DNA damage-inducible transcript 4-like protein, HIF-1 responsive protein RTP801-like, Protein regulated in development and DNA damage response 2, REDD-2
- WB
Supplier Data
Western blot - Anti-DDIT4L/REDD2 antibody [DDIT-03] - N-terminal (AB191096)
All lanes:
Western blot - Anti-DDIT4L/REDD2 antibody [DDIT-03] - N-terminal (ab191096)
Lane 1:
HEK293 transfected with DDIT4L plasmid
Lane 2:
Untransfected HEK293
Predicted band size: 22 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
DDIT4L/REDD2 influences response to cellular stress signals and acts as an inhibitor of the mTOR pathway—an essential regulator of cell metabolism growth and proliferation. It does not function as part of a large complex but interacts with other proteins to mediate its effects. By inhibiting mTOR activity DDIT4L can affect protein synthesis and autophagy reflecting its role in maintaining cellular homeostasis under stress conditions.
Pathways
DDIT4L/REDD2 is intricately involved in the mTOR signaling cascade and influences the PI3K/AKT pathway two important pathways in cellular metabolism. Within these pathways it is related to proteins like TSC2 (Tuberous Sclerosis Complex 2) and AKT. DDIT4L exerts its effect by modulating signal transduction that impacts cell survival and stress responses making it an important player in the adaptation to environmental changes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
NAR cancer 7:zcaf026 PubMed40918647
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nutrients 14: PubMed36297046
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com